Category Pharmaceutical Industry

North Dakota to Receive Nearly $3 Million in Whistleblower Lawsuit [Legal Monitor Worldwide]

Dec31

The state of North Dakota will be receiving nearly $3 million for its state Medicaid program as part of a whistleblower settlement between the federal government and a major pharmaceutical company.A Tuesday release from the North Dakota Department of Human Services announced that the state Medicaid program will receive about $2.99 million. The money comes […]

IGI Laboratories, Inc. Completes Its Sixth ANDA Filing For 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

BUENA, N.J., Dec. 31, 2013 /PRNewswire/ IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company. In accordance with the confidentiality agreement in place, the name of the company remains undisclosed. The agreement designates […]

With new multimillion-dollar grants, UCLA scientists take stem cell research to patients

Dec30

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California’s stem cell agency.The new grants to researchers at UCLA’s Eli and Edythe Broad […]

Enanta Pharmaceuticals Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Enanta Pharmaceuticals Inc. (Form S-8) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 4 documents filed with […]

Acadia Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Dec. 12, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Acadia Pharmaceuticals Inc. (Form 4) was posted on December 12, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed with […]

InSite Vision Updates on Positive Confirmatory Phase 3 Results for BromSite for Reduction of Inflammation and Pain after Cataract Surgery [Professional Services Close

Dec30

InSite Vision Inc. has announced top-line results from its recently completed confirmatory Phase 3 clinical trial of BromSite (ISV-303) for the reduction of inflammation and pain after cataract surgery. BromSite combines a low dose (0.075 percent) of the non- steroidal anti-inflammatory drug (NSAID) bromfenac with InSite Vision’s DuraSite drug delivery technology.In a release, the Company […]

Acelrx Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Dec. 16, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Acelrx Pharmaceuticals Inc. (Form 8-K) was posted on December 16, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 3 documents filed with […]

Sucampo Pharmaceuticals, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Sucampo Pharmaceuticals, Inc. (Form 4) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed with […]

Transcept Pharmaceuticals Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Dec. 16, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Transcept Pharmaceuticals Inc. (Form CT ORDER) was posted on December 16, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]

Enanta Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Dec. 13, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Enanta Pharmaceuticals Inc. (Form 4) was posted on December 13, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed with […]